<--- Back to Details
First PageDocument Content
Pharmaceutical industry / Business / Economics / Mir Imran / Novartis / Venture capital
Date: 2015-05-27 17:34:00
Pharmaceutical industry
Business
Economics
Mir Imran
Novartis
Venture capital

Novartis Bets on ‘Robotic Pill’ From Startup Rani Therapeutics ­ Venture Capital Dispatch ­ WSJ May 26, 2015, 4:18 PM ET

Add to Reading List

Source URL: a.wethrive.com

Download Document from Source Website

File Size: 557,57 KB

Share Document on Facebook

Similar Documents

Interview INTERVIEW: MIR IMRAN, RANI THERAPEUTICS Mir Imran has spent the last 35 years focusing on his passion: creating breakthrough medical innovations that have saved or improved the lives of millions of patients. M

DocID: 1kJyJ - View Document

Pharmaceutical industry / Business / Economics / Mir Imran / Novartis / Venture capital

Novartis Bets on ‘Robotic Pill’ From Startup Rani Therapeutics ­ Venture Capital Dispatch ­ WSJ May 26, 2015, 4:18 PM ET

DocID: 1a92y - View Document

Anoka County /  Minnesota / Medtronic / Biomedical engineering / St. Jude Medical / Medical device / Hennepin County /  Minnesota / Minnesota / Mir Imran / Artificial cardiac pacemaker / Medicine / Technology / Geography of Minnesota

Designn of Medical D Devices C Conference onferen

DocID: F0TA - View Document

Electrodiagnosis / Electrophysiology / Medicine / Biology / Neuroscience / CleveMed / Electroencephalography / Electrocorticography / Mir Imran / Neurotechnology / Brain-computer interfacing / Neurophysiology

FOR IMMEDIATE RELEASE Robert N. Schmidt named as Most Valuable Financial Professional of the Year for Neurotech Industry 28 OCT 2013: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) announced today that their CE

DocID: y5kt - View Document